Progenics Pharmaceuticals Inc. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
42,572.00
4,410.00
39,119.00
10,733.00
51,013.00
67,657
Depreciation, Depletion & Amortization
939.00
545.00
565.00
2,078.00
1,121.00
1,497
Other Funds
45.00
-
-
-
-
22,911
Funds from Operations
35,646.00
11,555.00
34,141.00
12,986.00
54,341.00
44,797
Changes in Working Capital
461.00
2,171.00
5,996.00
6,223.00
713.00
1,955
Net Operating Cash Flow
36,107.00
13,726.00
40,137.00
19,209.00
53,628.00
46,752
Capital Expenditures
137.00
714.00
370.00
4,286.00
269.00
Sale of Fixed Assets & Businesses
174.00
143.00
48.00
347.00
52.00
Purchase/Sale of Investments
1,100.00
2,400.00
-
-
-
Net Investing Cash Flow
3,025.00
1,829.00
6,816.00
4,307.00
217.00
Issuance/Reduction of Debt, Net
-
-
-
48,650.00
-
Net Financing Cash Flow
40,104.00
37,887.00
1,737.00
49,990.00
5,495.00
Net Change in Cash
7,022.00
53,442.00
45,199.00
64,806.00
48,267.00
Free Cash Flow
36,244.00
13,012.00
40,507.00
14,923.00
53,897.00
Deferred Taxes & Investment Tax Credit
362.00
989.00
133.00
1,811.00
11,435.00
1,548
Net Assets from Acquisitions
1,888.00
-
6,494.00
368.00
-
Change in Capital Stock
40,149.00
37,887.00
1,737.00
1,340.00
5,495.00
Exchange Rate Effect
-
-
17.00
86.00
83.00
About Progenics Pharmaceuticals
View Profile
